REFRACTORY DEDIFFERENTIATED LIPOSARCOMA

Clinical trials for REFRACTORY DEDIFFERENTIATED LIPOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY DEDIFFERENTIATED LIPOSARCOMA trials appear

Sign up with your email to follow new studies for REFRACTORY DEDIFFERENTIATED LIPOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New immune therapy tested for Tough-to-Treat bone and soft tissue cancers

Disease control Ongoing

This study is testing whether two immunotherapy drugs, oleclumab and durvalumab, can help control advanced sarcomas that have come back, stopped responding to treatment, or spread. It is for adults and teens (12+) with specific types of sarcoma, including angiosarcoma, dedifferen…

Matched conditions: REFRACTORY DEDIFFERENTIATED LIPOSARCOMA

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 18, 2026 14:41 UTC

REFRACTORY DEDIFFERENTIATED LIPOSARCOMA

Get alerted when new REFRACTORY DEDIFFERENTIATED LIPOSARCOMA trials appear

New immune therapy tested for Tough-to-Treat bone and soft tissue cancers